Navigating the Canadian copyright situation presents a tricky challenge. To be blunt , dimethyltryptamine (copyright) remains entirely against the law across this territory. There are no sanctioned sources accessible for acquisition . However, surprisingly, the regulated status of psilocybin, and the expanding acceptance of copyright therapy , have